SARS-CoV-2 CD8+ T cell killing assays using replicating viruses and transgenic antigens

STAR Protoc. 2022 Dec 16;3(4):101699. doi: 10.1016/j.xpro.2022.101699. Epub 2022 Aug 26.

Abstract

The quality of an antigen-specific CD8+ T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8+ T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiological system for antigen presentation. We detail the use of target cells either infected with replicating SARS-CoV-2 virus or engineered with SARS-CoV-2 open reading frames. For complete details on the use and execution of this protocol, please refer to Moosmann et al. (2022) and Wagner et al. (2022).

Keywords: CRISPR; Cell Biology; Cell culture; Cell-based Assays; Immunology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Antigen Presentation
  • CD8-Positive T-Lymphocytes
  • COVID-19*
  • Cell Death
  • SARS-CoV-2*